Hepatic steatosis is closely related to insulin resistance, diabetes mellitus or metabolic syndrome, and is associated with increased risk of cardiovascular and renal disease.74 Hepatic steatosis has been associated with the prevalence and incidence of renal disease
Choose Saxenda if: You prefer daily dosing, want FDA-approved weight loss medication with an established safety record, didnt respond well to semaglutide, or prefer a shorter-acting medication
Metabolic Processing GIP-related activity is studied for its role in insulin signalling and how efficiently the body converts nutrients into energy
Please contact support or use WhatsApp to confirm current availability
Our approach to personalized care includes: Initial Medical Screening: Before starting, you complete a free assessment quiz that reviews your health history, current BMI, and weight loss goals